In a nutshell
Tethis’ innovative platform, See.d®, performs a completely automated, standardized and gentle preparation of a blood sample at the point of blood collection. Cellular fraction is gently stabilized on proprietary, nanocoated SBS slides for rare cell detection, including CTCs, while plasma is made available for the analysis of cell-free content. See.d® and SBS slides are for Research Use Only, not for use in diagnostic procedures.
EACR Liquid Biopsy conference
The See.d® platform will be presented at
the next EACR Liquid Biopsy conference to be held in
Bergamo, Italy, on May 24th-26th, 2022.